Can we predict local recurrence in breast conserving surgery after neoadjuvant chemotherapy?

Cebrecos, I; Córdoba, O; Deu, J; Xercavins, J; Rubio, I T

Cebrecos, I; Córdoba, O; Deu, J; Xercavins, J; Rubio, I T.

Affiliation

Cebrecos I; Breast Surgical Unit, Department of Gynaecology, Hospital Universitario Vall d'Hebron, Passeig Vall d'Hebron 119, 08035 Barcelona, Spain.

Eur J Surg Oncol ; 36(6): 528-34, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20444571

Subject(s)

Breast Neoplasms/pathology; Breast Neoplasms/surgery; Mastectomy, Segmental; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local/epidemiology; Neoplasm Recurrence, Local/pathology; Neoplasm Staging; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Survival Rate

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mastectomy, Segmental Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google